PL352827A1 - Substituted polycyclic aryl and heteroaryl pyrymidinones useful as anticoagulants - Google Patents
Substituted polycyclic aryl and heteroaryl pyrymidinones useful as anticoagulantsInfo
- Publication number
- PL352827A1 PL352827A1 PL00352827A PL35282700A PL352827A1 PL 352827 A1 PL352827 A1 PL 352827A1 PL 00352827 A PL00352827 A PL 00352827A PL 35282700 A PL35282700 A PL 35282700A PL 352827 A1 PL352827 A1 PL 352827A1
- Authority
- PL
- Poland
- Prior art keywords
- pyrymidinones
- anticoagulants
- heteroaryl
- useful
- polycyclic aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13479499P | 1999-05-19 | 1999-05-19 | |
PCT/US2000/009806 WO2000069832A1 (en) | 1999-05-19 | 2000-05-17 | Substituted polycyclic aryl and heteroaryl pyrymidinones useful as anticoagulants |
Publications (1)
Publication Number | Publication Date |
---|---|
PL352827A1 true PL352827A1 (en) | 2003-09-08 |
Family
ID=22465042
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL00352827A PL352827A1 (en) | 1999-05-19 | 2000-05-17 | Substituted polycyclic aryl and heteroaryl pyrymidinones useful as anticoagulants |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1178970A1 (en) |
JP (1) | JP2002544262A (en) |
KR (1) | KR20010114271A (en) |
CN (1) | CN1157380C (en) |
AR (1) | AR030021A1 (en) |
AU (2) | AU771718B2 (en) |
BR (1) | BR0010758A (en) |
CA (1) | CA2373614A1 (en) |
CZ (1) | CZ20014116A3 (en) |
EA (1) | EA004867B1 (en) |
HU (1) | HUP0201242A3 (en) |
IL (1) | IL146243A0 (en) |
MX (1) | MXPA01011804A (en) |
NO (1) | NO20015604L (en) |
NZ (1) | NZ514874A (en) |
PE (1) | PE20010229A1 (en) |
PL (1) | PL352827A1 (en) |
SK (1) | SK15852001A3 (en) |
TW (1) | TWI222445B (en) |
UY (1) | UY26156A1 (en) |
WO (1) | WO2000069832A1 (en) |
ZA (2) | ZA200109339B (en) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6653316B1 (en) | 1999-05-19 | 2003-11-25 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade |
US6750342B1 (en) | 1999-05-19 | 2004-06-15 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade |
US6867217B1 (en) | 1999-05-19 | 2005-03-15 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade |
MXPA01011806A (en) * | 1999-05-19 | 2003-09-04 | Pharmacia Corp | Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents. |
US7015230B1 (en) | 1999-05-19 | 2006-03-21 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade |
US6664255B1 (en) | 1999-05-19 | 2003-12-16 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
US6716838B1 (en) | 1999-05-19 | 2004-04-06 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents |
US6458952B1 (en) | 1999-05-19 | 2002-10-01 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade |
US6852761B2 (en) | 2000-03-13 | 2005-02-08 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade |
WO2001077079A2 (en) | 2000-04-05 | 2001-10-18 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade |
AU2001249870A1 (en) | 2000-04-05 | 2001-10-23 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade |
AU2001253363A1 (en) | 2000-04-17 | 2001-10-30 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade |
WO2001087851A1 (en) * | 2000-05-18 | 2001-11-22 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade |
US6710058B2 (en) | 2000-11-06 | 2004-03-23 | Bristol-Myers Squibb Pharma Company | Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors |
JP2004517074A (en) | 2000-11-20 | 2004-06-10 | ファルマシア・コーポレーション | Substituted polycyclic aryl and heteroaryl pyridines useful for selectively inhibiting the coagulation cascade |
US7015223B1 (en) | 2000-11-20 | 2006-03-21 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade |
US7119094B1 (en) | 2000-11-20 | 2006-10-10 | Warner-Lambert Company | Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade |
BR0213099A (en) | 2001-10-03 | 2004-10-19 | Pharmacia Corp | Substituted 5-membered polycyclic compounds useful for selective inhibition of coagulation cascade |
MXPA04003167A (en) * | 2001-10-03 | 2004-07-08 | Pharmacia Corp | 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade. |
MXPA04003163A (en) | 2001-10-03 | 2004-07-08 | Pharmacia Corp | 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade. |
WO2003072107A1 (en) * | 2002-02-22 | 2003-09-04 | Pharmacia & Upjohn Company | Substituted pyrimidinones and pyrimidinthiones |
TW200307667A (en) | 2002-05-06 | 2003-12-16 | Bristol Myers Squibb Co | Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors |
US7217794B2 (en) | 2003-04-02 | 2007-05-15 | Daiamed, Inc. | Compounds and methods for treatment of thrombosis |
US7182738B2 (en) | 2003-04-23 | 2007-02-27 | Marctec, Llc | Patient monitoring apparatus and method for orthosis and other devices |
WO2006133242A2 (en) * | 2005-06-07 | 2006-12-14 | Pharmacopeia, Inc. | Azinone and diazinone v3 inhibitors for depression and stress disorders |
CN104311537B (en) * | 2014-09-19 | 2016-08-24 | 广东东阳光药业有限公司 | Containing pyrimidone acetyl substituents pyrazole compound and combinations thereof thing and purposes |
CN115779953B (en) * | 2022-12-19 | 2024-06-21 | 中南大学 | Copper-loaded carbon-based monoatomic material, and preparation method and application thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5441960A (en) * | 1992-04-16 | 1995-08-15 | Zeneca Limited | 1-pyrimidinylacetamide human leukocyte elastate inhibitors |
US5948785A (en) * | 1995-04-27 | 1999-09-07 | The Green Cross Corporation | Heterocyclic amide compounds and pharmaceutical use of the same |
-
2000
- 2000-05-17 HU HU0201242A patent/HUP0201242A3/en unknown
- 2000-05-17 CZ CZ20014116A patent/CZ20014116A3/en unknown
- 2000-05-17 EP EP00931928A patent/EP1178970A1/en not_active Withdrawn
- 2000-05-17 SK SK1585-2001A patent/SK15852001A3/en unknown
- 2000-05-17 MX MXPA01011804A patent/MXPA01011804A/en unknown
- 2000-05-17 IL IL14624300A patent/IL146243A0/en unknown
- 2000-05-17 JP JP2000618249A patent/JP2002544262A/en active Pending
- 2000-05-17 KR KR1020017014753A patent/KR20010114271A/en not_active Application Discontinuation
- 2000-05-17 EA EA200101214A patent/EA004867B1/en not_active IP Right Cessation
- 2000-05-17 PL PL00352827A patent/PL352827A1/en not_active Application Discontinuation
- 2000-05-17 AU AU49734/00A patent/AU771718B2/en not_active Ceased
- 2000-05-17 CA CA002373614A patent/CA2373614A1/en not_active Abandoned
- 2000-05-17 NZ NZ514874A patent/NZ514874A/en unknown
- 2000-05-17 WO PCT/US2000/009806 patent/WO2000069832A1/en not_active Application Discontinuation
- 2000-05-17 CN CNB008077479A patent/CN1157380C/en not_active Expired - Fee Related
- 2000-05-17 BR BR0010758-1A patent/BR0010758A/en not_active IP Right Cessation
- 2000-05-19 AR ARP000102446A patent/AR030021A1/en unknown
- 2000-05-19 UY UY26156A patent/UY26156A1/en not_active Application Discontinuation
- 2000-06-09 PE PE2000000575A patent/PE20010229A1/en not_active Application Discontinuation
- 2000-07-25 TW TW089109595A patent/TWI222445B/en not_active IP Right Cessation
-
2001
- 2001-11-13 ZA ZA200109339A patent/ZA200109339B/en unknown
- 2001-11-16 NO NO20015604A patent/NO20015604L/en not_active Application Discontinuation
-
2004
- 2004-01-21 ZA ZA200400448A patent/ZA200400448B/en unknown
- 2004-05-31 AU AU2004202375A patent/AU2004202375A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ZA200109339B (en) | 2004-05-26 |
NO20015604L (en) | 2002-01-11 |
BR0010758A (en) | 2003-06-10 |
EA004867B1 (en) | 2004-08-26 |
NZ514874A (en) | 2004-11-26 |
JP2002544262A (en) | 2002-12-24 |
IL146243A0 (en) | 2002-07-25 |
AR030021A1 (en) | 2003-08-13 |
EP1178970A1 (en) | 2002-02-13 |
AU771718B2 (en) | 2004-04-01 |
SK15852001A3 (en) | 2003-06-03 |
TWI222445B (en) | 2004-10-21 |
AU2004202375A1 (en) | 2004-06-24 |
ZA200400448B (en) | 2004-09-29 |
NO20015604D0 (en) | 2001-11-16 |
PE20010229A1 (en) | 2001-03-07 |
MXPA01011804A (en) | 2003-09-04 |
HUP0201242A2 (en) | 2002-12-28 |
HUP0201242A3 (en) | 2003-02-28 |
WO2000069832A1 (en) | 2000-11-23 |
CN1157380C (en) | 2004-07-14 |
EA200101214A1 (en) | 2002-06-27 |
CN1351593A (en) | 2002-05-29 |
KR20010114271A (en) | 2001-12-31 |
UY26156A1 (en) | 2000-12-29 |
CA2373614A1 (en) | 2000-11-23 |
CZ20014116A3 (en) | 2002-06-12 |
AU4973400A (en) | 2000-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL146243A0 (en) | Substituted polycyclic aryl and heteroaryl pyrymidinones useful as anticoagulants | |
IL131195A0 (en) | Remote laboratory | |
AU4145200A (en) | Cyclic compounds and uses thereof | |
GB9923894D0 (en) | Accelerometer | |
EP1223932A4 (en) | Compounds and methods | |
EP1146790A4 (en) | Compounds and methods | |
ZA200109338B (en) | Substituted polycyclic aryl and heteroaryl uracils as anti-coagulative agents. | |
HK1045312A1 (en) | Cyclic compound | |
GB0000276D0 (en) | Capacitor | |
PL353372A1 (en) | Substituted heterocyclyl-2h-chromenes | |
IL150200A0 (en) | Substituted pyrroles | |
GB9922942D0 (en) | Catch | |
GB9911456D0 (en) | Oligohydroxyl substituted 3-urea-benzofurane-and-pyridofurane-derivatives | |
GB9922530D0 (en) | Distractor | |
PL352101A1 (en) | Substituted phenylcyclohexanocarboxyamides | |
GB9929107D0 (en) | Window component etc | |
GB9921851D0 (en) | Structural elements | |
GB9929433D0 (en) | Cyclic compound | |
GB2357543B (en) | Structural members | |
HU0000970D0 (en) | Rapid fastening set | |
GB9905450D0 (en) | Crane | |
AU139821S (en) | Height chart | |
PL332520A1 (en) | Organomineral sorbent | |
GB9927083D0 (en) | Rodenticides | |
GB9929538D0 (en) | Rodenticides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |